Editorial: Should we evaluate insulin sensitivity in rheumatoid arthritis?

Seminars in Arthritis and Rheumatism

Volumn 35, Issue 1, 2005, Pages 5-7

  Dessein, Patrick H ^a,c   Joffe, Barry I ^a   Stanwix, Anne E ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c NONE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROGENESIS; CARDIOVASCULAR RISK; CLINICAL FEATURE; DISEASE ASSOCIATION; EDITORIAL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT;

ARTHRITIS, RHEUMATOID; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 23444452711     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2005.03.008     Document Type: Editorial

References (26)

1. F. Wolfe, B. Freundlich, W.L. Straus Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis J Rheumatol 30 2003 36 40
2. I.D. del Rincon, K. Williams, M.P. Stern, G.L. Freeman, A. Escalante High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors Arthritis Rheum 44 2001 2737 2745
3. H.M. Colhoun, D.J. Betteridge, P.N. Durrington, G.A. Hitman, H.A. Neil, S.J. Livingstone Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomized placebo-controlled trial Lancet 364 2004 685 696
4. M. Naghavi, P. Libby, E. Falk, S.W. Casscells, S. Litovsky, J. Rumberger From vulnerable plaque to vulnerable patient A call for new definitions and risk assessment strategies: Part II Circulation 108 2003 1772 1778
5. S. Wallberg-Jonsson, M.L. Ohman, S.R. Dahlqvist Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden J Rheumatol 24 1997 445 451
6. I. del Rincon, K. Williams, M.P. Stern, G.L. Freeman, D.H. O'Leary, A. Escalante Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects Arthritis Rheum 48 2003 1833 1840
7. M. Nagata-Sakurai, M. Inaba, H. Goto, Y. Kumeda, Y. Furumitsu, K. Inui Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis Arthritis Rheum 48 2003 3061 3067
8. F. Wolfe, K. Michaud Prednisone but not biologics or disease modifying agent is associated with increased risk of myocardial infarction in persons with RA Ann Rheum Dis 63 Suppl 1 2004 69
9. S. Suissa, S. Bernatsky, M. Hudson, A. Kezouth Disease modifying agent use and the risk of acute myocardial infarction in rheumatoid arthritis Ann Rheum Dis 63 Suppl 1 2004 69
10. H.K. Choi, M.A. Hernan, J.D. Seeger, J.M. Robins, F. Wolfe Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study Lancet 359 2002 1173 1177
11. N. Sattar, D.W. McCarey, H. Capell, I.B. McInnes Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis Circulation 108 2003 2957 2963
12. P.H. Dessein, B.I. Joffe, A.E. Stanwix, B.F. Christian, M. Veller Glucocorticoids and insulin sensitivity in rheumatoid arthritis J Rheumatol 31 2004 867 874
13. P.H. Dessein, A.E. Stanwix, B.I. Joffe Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis Arthritis Res 4 2002 R5
14. E. Hurt-Camejo, S. Paredes, L. Masana, G. Camejo, P. Sartipy, B. Rosengren Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile Arthritis Rheum 44 2001 2761 2767
15. R.M. Krauss, P.W. Siri Metabolic abnormalities: triglyceride and low-density lipoprotein Endocrinol Metab Clin North Am 33 2004 105 115
16. J.P. Despres, B. Lamarche, P. Mauriege, B. Cantin, G.R. Dagenais, S. Moorjani Hyperinsulinemia as an independent risk factor for ischaemic heart disease N Engl J Med 334 1996 952 957
17. A.D. Pradhan, J.E. Manson, J.B. Meigs, N. Rifai, J.E. Buring, S. Liu Insulin, pro-insulin, pro-insulin:insulin ratio and the risk of developing type 2 diabetes mellitus in women Am J Med 114 2003 438 444
18. S.M. Grundy, B. Bryan Brewer Jr, J.I. Cleeman, S.C. Smith, C. Lenfant Definition of metabolic syndrome Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition Circulation 109 2004 433 438
19. World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO Consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva, Switzerland: World Health Organization; 1999. Available at: http://whqlibdoc.who.int/hq/ 1999WHONCDNCS99.2.pdf. Accessed December 12, 2003.
20. Grundy SM, Becker D, Clark LT, et al. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002;106:3143-421.
21. Y. Liao, S. Kwon, S. Shaughnessy, P. Wallace, A. Hutto, A.J. Jenkins Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia Diabetes Care 27 2004 978 983
22. R. Hallgren, C. Berne Glucose intolerance in patients with chronic inflammatory diseases is normalized by glucocorticoids Acta Med Scand 213 1983 351 355
23. K.L. Svenson, T. Pollare, H. Lithell, R. Hallgren Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance Metabolism 37 1988 125 130
24. P.H. Dessein, B.I. Joffe, A.E. Stanwix Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis - a pilot study Arthritis Res 4 2002 R12
25. F. Wolfe, K. Michaud Corticosteroids increase the risk of diabetes mellitus in RA and contribute to the risk of myocardial infarction and heart failure Ann Rheum Dis 63 Suppl 1 2004 495
26. P.H. Dessein, B.I. Joffe, A.E. Stanwix Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis Thyroid 14 2004 443 446